All these presentations are wonderful and hopefully gather more notice than previous conferences and papers have.  I fear that the world is passing RVX by the longer we wait.  How can a drug that supposedly had an eight year lead on the rest of the world still be no closer to commercialization than it was many, many years ago?  And that eight year lead must be down to a very small lead if any remaining after all this time.  Other companies have not sat still waiting for RVX to get some traction.  

Excellent science doesn't mean anything if they can't get a product to market. Show me SOME money, any money after all these years of death by a thousand cuts........ One set of warrants expired in June and I have another set expiring in September.  A result of a " friends and family round" at .80 cents last year with a (soon to be useless) 1/2 warrant attached.  I wish RVX didn't treat their share holders as nothing more than deep pockets with no rights to any information.